Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 100 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 50 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - fluquinconazole - suspension concentrates for seed treatment (fs) - fluquinconazole azole active 167.0 g/l - fungicide

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - zinc chloride, quantity: 5.3 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

arysta lifescience australia pty ltd - fluquinconazole - suspension concentrates for seed treatment (fs) - fluquinconazole azole active 167.0 g/l - fungicide - barley | canola | wheat | rapeseed - barley leaf scald | barley loose smut - ustilago nuda var ho | blackleg - suppression | covered smut (bunt) - tilletia spp. | leaf rust | loose smut - ustilago tritici | powdery mildew | septoria tritici blotch - supression | smut - ustilago segetum var hordei | stripe rust | take-all of wheat | barley scald | bunt | common bunt | covered smut | puccinia recondita f.sp. triti | puccinia triticina | take-all of wheat - suppressio | ustilago nuda var hordei | wheat leaf rust

Australia - English - Department of Health (Therapeutic Goods Administration)

amgen australia pty ltd - blinatumomab, quantity: 38.5 microgram/g - injection, solution - excipient ingredients: citric acid monohydrate; lysine hydrochloride; polysorbate 80; sodium hydroxide; water for injections - blincyto is indicated for the treatment of relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).,blincyto is indicated for the treatment of minimal residual disease (mrd) positive b-cell precursor acute lymphoblastic leukaemia (all) in patients in complete haematological remission.,note to indication: the indications in philadelphia positive, mrd positive and paediatric patients were approved based on phase ii, non-randomised evidence. an improvement in clinical outcomes by direct prospective comparison in a randomised setting relative to other standard-of-care salvage therapies has not been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

vitahealth laboratories australia pty ltd - magnesium amino acid chelate,pyridoxine hydrochloride,retinol acetate,zinc amino acid chelate,zinc citrate dihydrate,zinc gluconate -

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - zinc chloride, quantity: 5.3 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing. indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing.

Australia - English - Department of Health (Therapeutic Goods Administration)

market australia inc - ascorbic acid,boswellia serrata,copper gluconate,glucosamine sulfate potassium chloride,humulus lupulus,manganese sulfate monohydrate,phytomenadione,scutellaria baicalensis,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

market australia inc - ascorbic acid,betacarotene,biotin,calcium carbonate,calcium pantothenate,calcium phosphate,calcium sulfate dihydrate,chromium nicotinate,colecalciferol,cyanocobalamin,dl-alpha-tocopheryl acetate,folic acid,magnesium carbonate hydrate,manganese sulfate monohydrate,nicotinamide,potassium iodide,pyridoxine hydrochloride,riboflavin,selenomethionine,thiamine hydrochloride,zinc gluconate -